SPDR® S&P Biotech ETF (XBI)

BATS BZX Real-Time Price
As of 1:37pm ET
 +0.03 / +0.02%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI").


1 month-8.14% 3 years+15.24%
3 months-13.13% 5 years+18.62%
1 year+55.98% Since inception+14.90%
Data through 04/10/2021

Quote Details

Previous close$127.05
Open day’s range126.10 – 128.88
Net asset value (NAV)129.86 (04/09/2021)
Daily volume3,326,879
Average volume (3 months)6,149,825
Data as of 1:37pm ET, 04/13/2021

Peer Comparisonvs. Health ETFs

Performance 5-yr return+18.62%+15.28%
Expense Gross exp ratio0.35%1.02%
Risk 5 year sharpe ratio0.780.80
Net assets$7.3B$2.3B
Average market cap$2.5B$31.9B
Average P/E--27.0
Dividend / Share--0.29%


IEHS iShares Evolved U.S. Healthcare Staples ...
VHT Vanguard Health Care Index Fund ETF Shar...
FHLC Fidelity MSCI Health Care Index ETF


Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
NTLA Intellia Therapeutics Inc0.84%
VCEL Vericel Corp0.81%
HGEN Humanigen Inc0.81%
CLVS Clovis Oncology Inc0.81%
ICPT Intercept Pharmaceuticals Inc0.75%
SGMO Sangamo Therapeutics Inc0.74%
AMGN Amgen0.74%
MGNX MacroGenics Inc0.72%
BIIB Biogen0.72%
GILD Gilead Sciences0.72%